Tagged with Global

Biosimilars: Should I Stay or Should I Go?
Oncology: Ripe for Decentralised Research
Five Leading Biosimilars Companies 2022
Is 2022 the Pharma Industry’s ‘Call of Duty’ Moment?
Astellas CMO Bernie Zeiher: Leaving No Stone Unturned in the Quest for Patient Value
Vaccine Nationalism: “Moral Obscenity, Public Health Catastrophe & Economic Folly”
CAR-T Patient Engagement Roundtable: A Varied Global Picture
CGT, Real World Evidence & The Patient Experience
CAR-T and the Art of Managing Expectations
Rendering Cell & Gene Therapy Genuinely Patient Centric
J.P. Morgan Healthcare Conference 2022: Glass Half Full
Ipsen EVP and CBO Philippe Lopes-Fernandes on the company’s deal-making philosophy
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here